Skip to main content

Peer Review reports

From: Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

Original Submission
10 Jan 2011 Submitted Original manuscript
7 Apr 2011 Author responded Author comments - Michael Fiegl
Resubmission - Version 2
7 Apr 2011 Submitted Manuscript version 2
29 Apr 2011 Reviewed Reviewer Report - Jens Huober
21 May 2011 Reviewed Reviewer Report - Volkmar Muller
27 Jun 2011 Author responded Author comments - Michael Fiegl
Resubmission - Version 3
27 Jun 2011 Submitted Manuscript version 3
2 Jul 2011 Author responded Author comments - Michael Fiegl
Resubmission - Version 4
2 Jul 2011 Submitted Manuscript version 4
10 Jul 2011 Author responded Author comments - Michael Fiegl
Resubmission - Version 5
10 Jul 2011 Submitted Manuscript version 5
12 Jul 2011 Author responded Author comments - Michael Fiegl
Resubmission - Version 6
12 Jul 2011 Submitted Manuscript version 6
Publishing
24 Aug 2011 Editorially accepted
24 Aug 2011 Article published 10.1186/1471-2407-11-373

You can find further information about peer review here.

Back to article page